FPS
CNMD icon

Fieldpoint Private Securities’s CONMED CNMD Stock Holding History

Fieldpoint Private Securities’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$7K Sell
75
-90
-55% -$10.8K ﹤0.01% 808
2022
Q1 		$25K Hold
165
– – 0.01% 781
2021
Q4 		$23K Hold
165
– – ﹤0.01% 827
2021
Q3 		$22K Hold
165
– – ﹤0.01% 798
2021
Q2 		$20K Hold
165
– – ﹤0.01% 801
2021
Q1 		$22K Hold
165
– – 0.01% 755
2020
Q4 		$18K Buy
+165
New +$15.6K ﹤0.01% 715

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fieldpoint Private Securities's CNMD Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its CONMED (CNMD) stake by 55% in Q2 2022, selling an estimated $10.8K and leaving 75 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

Fieldpoint Private Securities first reported a position in CNMD in Q4 2020 and has held it in 7 quarters since. The position peaked at $25K in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

  • Fieldpoint Private Securities held 75 shares of CONMED worth $7K as of Q2 2022.
  • Fieldpoint Private Securities sold 90 CONMED shares in Q2 2022, an estimated $10.8K.
  • CONMED made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #808 holding.
  • Fieldpoint Private Securities first reported a position in CONMED in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's CONMED position peaked at $25K in Q1 2022.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.